Methods and apparatus for percutaneous aortic valve replacement

• US 8,663,319 B2
• Filed: 07/25/2008
• Issued: 03/04/2014
• Est. Priority Date: 07/23/2007
• Status: Active Grant

• Current Assignee: Hocor Cardiovascular Technologies, LLC
• Original Assignee: Hocor Cardiovascular Technologies, LLC
• Inventors: Ho, Paul C.
• Primary Examiner(s): TYSON, MELANIE RUANO
• Application Number:
  US12/180,223
• Publication Number:
  US 20090030510A1
• Time in Patent Office: 2,048 Days
• Field of Search: 623/1.26, 623/2.1, 623/2.11, 128/898, 128/899
• US Class Current: 623/2.11
• CPC Class Codes: A61B 17/12036 partial occlusion
• CPC Class Codes: A61B 17/1204 temporary occlusion
• CPC Class Codes: A61B 17/12109 in a blood vessel
• CPC Class Codes: A61B 17/12122 within the heart for closing a cardiac septal defect A61B17/0057
• CPC Class Codes: A61B 17/12136 Balloons
• CPC Class Codes: A61B 2017/00703 correcting for movement of heart, e.g. ECG-triggered
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/2433 using balloon catheter
• CPC Class Codes: A61F 2250/0059 temporary
• CPC Class Codes: A61F 2250/006 modular

Abstract

A delivery system and method for percutaneous aortic valve (PAV) replacement and apparatus used therein. A temporary aortic valve including a reversibly expandable occluding means surrounds a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The temporary valve substitutes for the function of the native aortic valve during its replacement. The native aortic valve is next dilated, and then ablated through deployment of low profile, elongated, sequentially delivered stents. The stent(s) displace the native tissues and remain within the aortic annulus to receive and provide a structure for retaining the PAV. The PAV is delivered, positioned and deployed within the stent(s) at the aortic annulus with precision and relative ease.

Claims

1. A method for percutaneous aortic valve replacement, said method comprising:

advancing a central catheter through the ascending aorta toward the aortic valve to position a temporary aortic valve in the ascending aorta;

deploying the temporary aortic valve against the wall of the ascending aorta;

advancing a stent catheter over a guidewire positioned within and through the central catheter to place an ablation stent within the aortic valve;

deploying the ablation stent within the native aortic valve;

withdrawing the stent catheter; and

advancing a deployment catheter over the guidewire positioned within and through the central catheter to place a replacement valve in the ablation stent while the temporary aortic valve and the ablation stent remain in place.

2. The method of claim 1 wherein the temporary aortic valve is deployed within the ascending aorta prior to deploying the ablation stent within the native aortic valve.

3. The method of claim 2 wherein the native aortic valve is pre-dilated prior to advancing of the central catheter.

4. The method of claim 2 wherein the native aortic valve is pre-dilated following advancing of the central catheter and prior to ablation of the native aortic valve.

5. The method of claim 1 wherein the native aortic valve is ablated with a plurality of low-profile stents sequentially delivered and concentrically deployed one within the other.

6. The method of claim 5, wherein the number of concentrically deployed low-profile stents ranges from at least 2.

7. The method of claim 1 wherein said ablation stent is advanced into position within the aortic annulus in an elongated form and foreshortens during deployment.

8. The method of claim 1 wherein the central catheter has a diameter within the range of 8 to 12 French.

9. The method of claim 1 wherein the central catheter has a diameter within the range of 12 to 18 French.

10. The method of claim 1 wherein the central catheter has a diameter within the range of 8 to 18 French.

11. The method of claim 1 wherein said replacement valve is a low-profile valve with compact frame deployment within and secured by said ablation stent.

12. The method of claim 1 wherein said ablation stent is fabricated from high strength composite material.

13. The method of claim 11 wherein said replacement valve is framed using high strength composite material.

14. The method of claim 1, wherein said ablation stent has drug-elution capabilities.

15. The method of claim 1, wherein the temporary aortic valve comprises an inflatable balloon structure.

16. The method of claim 15, wherein the balloon structure has gaps.

17. The method of claim 16, wherein the gaps are in the range from 25% to 60% of the cross-sectional area of the aortic valve.

18. The method of claim 16, wherein the balloon structure comprises a plurality of inflatable balloons disposed circumferentially about the central catheter.